Benzinga | Aug 9, 2021 04:33PM EDT

Amphastar Pharmaceuticals Q2 Adj. EPS $0.21, Inline, Sales $101.70M Miss $101.78M Estimate

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported quarterly earnings of $0.21 per share which met the analyst consensus estimate. This is a 31.25 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $101.70 million which missed the analyst consensus estimate of $101.78 million by 0.08 percent. This is a 18.52 percent increase over sales of $85.81 million the same period last year.